FdaApplication

ANDA 087004

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIVAX PHARMACEUTICALS INC
application_typeANDA
approval_date1982-05-24

Products (1)

ProductActive ingredientStrengthDosage form
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; SPIRONOLACTONE25MG;25MGTABLET;ORAL

1 product